Thomas Jefferson University Hospitals Inc, branded as Jefferson Health, is a multi-state non-profit health system whose flagship hospital is Thomas Jefferson University Hospital in Center City, Philadelphia. The health system's hospitals serve as the teaching hospitals of Thomas Jefferson University.

During the past decade, Thomas Jefferson University Hospital conducted 361 clinical trials. In the 10-year time frame, 361 clinical trials started and 172 clinical trials were completed, i.e. on average, 47.6% percent of trials that started reached the finish line to date. In the past 5 years, 165 clinical trials started and 101 clinical trials were completed. i.e. 61.2% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Thomas Jefferson University Hospital" #1 sponsor was "National Cancer Institute (NCI)" with 130 trials, followed by "Thomas Jefferson University" with 84 trials sponsored, "NRG Oncology" with 19 trials sponsored, "National Institute of Allergy and Infectious Diseases (NIAID)" with 16 trials sponsored and "ECOG-ACRIN Cancer Research Group" with 16 trials sponsored. Other sponsors include 325 different institutions and companies that sponsored additional 191 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Thomas Jefferson University Hospital" #1 collaborator was "National Cancer Institute (NCI)" with 91 trials as a collaborator, "NRG Oncology" with 43 trials as a collaborator, "Thomas Jefferson University" with 14 trials as a collaborator, "National Institute of Neurological Disorders and Stroke (NINDS)" with 12 trials as a collaborator and "National Heart, Lung, and Blood Institute (NHLBI)" with 10 trials as a collaborator. Other collaborators include 349 different institutions and companies that were collaborators in the rest 221 trials.

According to Clinical.Site data, the most researched conditions in "Thomas Jefferson University Hospital" are "HIV Infections" (17 trials), "Heart Failure" (13 trials), "Breast Cancer" (10 trials), "Pain" (10 trials) and "Prostate Cancer" (9 trials). Many other conditions were trialed in "Thomas Jefferson University Hospital" in a lesser frequency.

Most popular intervention types in "Thomas Jefferson University Hospital" are "Drug" (392 trials), "Other" (177 trials), "Biological" (117 trials), "Procedure" (91 trials) and "Radiation" (81 trials). Other intervention types were less common.

The name of intervention was led by "Laboratory Biomarker Analysis" (76 trials), "Quality-of-Life Assessment" (61 trials), "Placebo" (53 trials), "Questionnaire Administration" (37 trials) and "Biospecimen Collection" (34 trials). Other intervention names were less common.

The vast majority of trials in "Thomas Jefferson University Hospital" are 474 trials for "All" genders, 92 trials for "Female" genders and 27 trials for "Male" genders.

Currently, there are 268 active trials in "Thomas Jefferson University Hospital". 2 are not yet recruiting, 120 are recruiting, 144 are Active, not recruiting, and 2 are Enrolling by invitation. In total, there were 220 completed trials in Thomas Jefferson University Hospital, 11 suspended trials, and 57 terminated clinical trials to date.

Out of the total trials that were conducted in Thomas Jefferson University Hospital, 83 "Phase 1" clinical trials were conducted, 198 "Phase 2" clinical trials and 205 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 23 trials, and there were also 83 trials that are defined as “Not Applicable".